NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

3.76 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Operating Activities:
Net Income -1.623-7.897-6.528-4.332-6.062-8.717-11.039-10.241-9.083-6.982-13.448-30.793-20.773-16.008-25.489-45.128-5.1620-0.002-0.0020.0590.1760.1880.0290.028-0.0070.015-0.105
Depreciation & Amortization 0.0020.0010.0010.0010.0020.0010.0010.0010.0010.0010.00100.0010.00100.0010.00100000000000
Deferred Income Tax 0002.202-0.0260.0110000000.26-1.46802.6942.6900000000000
Stock Based Compensation 0.1040.0970.242-1.2030.3510.5440.6950.7660.5410.9871.3341.571.564.2830.3720.3570.191000.00100000000
Change In Working Capital 0.0433.0472.2872.4220.812-0.5642.4940.672.238-6.23.991-0.938-1.402-3.410.8522.1111.142-00.317-0.1190.046-0.0360.094-0.285-0.25-0.271-0.173-0.001
Accounts Receivables 00000000000-00.83100.8310.423-0.94-00000000000
Change In Inventory 00000000000-0.815-10.47612.19302.3624.04700000000000
Change In Accounts Payables 0.742.1182.0911.0011.525-1.5691.698-0.092-0.91-1.2330.624-1.873-0.7091.3341.229-0.1470.768-0.0160.0430.0850.105-0.014-0.1050.2240.1230.143-0.0250.086
Other Working Capital -0.6970.9290.1961.421-0.7131.005-1.6980.7623.148-4.9673.3671.758.951-16.938-1.208-0.527-2.733-0.0090.274-0.204-0.059-0.0220.198-0.509-0.373-0.415-0.149-0.087
Other Non Cash Items -0.5231.247-1.52-2.2820.3590.9131.760.4860.037-2.597-2.25818.888.3395.2121.2539.5580.00800.0010.001-0.158-0.32-0.5790.1850.1550.141-0.04-0.029
Operating Cash Flow -1.997-3.505-3.671-3.192-4.564-7.812-6.089-8.318-6.266-14.791-10.38-11.28-12.015-11.393-3.015-0.407-1.130-0.001-0.001-0.052-0.181-0.298-0.071-0.067-0.137-0.198-0.136
Investing Activities:
Investments In Property Plant And Equipment 0000.004-0.0020.002-0.0040.001-0.005-0.003-0.003-0-0.004-0.0030-0.002000-000000000
Acquisitions Net 00000000000000025.959000000000000
Purchases Of Investments 000-0.003000-0.01000-0.0070000.19300-0.193-0.139-0.1640-0.690000-69
Sales Maturities Of Investments 000000000000000-26.1190026.1199.7839.09622.1790.1820.0050.0050.010.0230
Other Investing Activites 000-0.00300-0.0040.0100-0.0030.033000-0.0330.306-0.02325.92640.24700-0.508-0.69000.0230
Investing Cash Flow 0000.001-0.0020.002-0.0040.001-0.005-0.003-0.003-0-0.004-0.0030-0.0020.306-0.02325.926-08.93122.179-0.508-0.6850.0050.010.023-69
Financing Activities:
Debt Repayment -0.224-0.001-2.155-1.116-2.6720.696010.020000-0.17600-0.010.0100.22900.2050.100000-0.1
Common Stock Issued 0.2193.1422.55-8.1221.1715.5772.5450.092-0.028-0.34222.980.00128.4941.5626.9270.991.412000000000-0.00869.603
Common Stock Repurchased 000000000000000000-25.998-9.736-8.891-22.099000000
Dividends Paid 000000000000000-26.527000000000000
Other Financing Activities 2.0590000000.1020-0.5180-09.1999.957.5-000.001-25.9980.16000.7970.690000.083
Financing Cash Flow 2.0543.1410.395-1.116-1.5016.2732.54510.122-0.028-0.8622.980.00137.51611.51214.4270.981.4220.0010-9.576-8.686-21.9990.7970.6900-0.00869.585
Other Information:
Effect Of Forex Changes On Cash 0007.180-7.1800000-1.8450-0.1020-0.611-0.55800000000000
Net Change In Cash -0.2520.579-3.276-4.307-6.067-1.537-3.5481.805-6.299-15.65412.597-11.27925.4970.11511.4120.5710.2920.001-0.001-0.1930.193-0-0.009-0.066-0.063-0.128-0.1820.449
Cash At End Of Period 1.6461.8981.3194.5958.90214.96916.50620.05418.24924.54840.20227.60538.88413.38613.2711.8591.2880.00100.0010.1940.0010.0020.0110.0770.140.2670.449